• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding

    The Baseline

    12
    Following
    368
    Stocks Tracked
    49
    Sectors & Interests
    Follow
    Load latest
    logo
    The Baseline
    12 Sep 2022
    Five analyst stock picks trading in the PE Buy Zone

    Five analyst stock picks trading in the PE Buy Zone

    By Abhiraj Panchal

    This week we take a look at five analyst picks that are also trading in the PE Buy Zone. The PE buy zone is a useful valuation check - it sees whether the stock trades at its current PE the majority of the time.

    If the current PE is unusually low compared to where the stock usually trades, the stock is in the PE buy zone. If the current PE is unusually high for the stock compared to its previous history, it is in the PE sell zone. 

    1. Healthcare Global Enterprises: ICICI Securities maintains its ‘Buy’ rating on this healthcare facilities company with a target price of Rs 339, indicating an upside of 25%. This stock is currently trading in the PE Buy Zone.

    Analysts Vinay Bafna and Rohan John are positive on the hospital chain as it focuses on its core competency area of oncology. They believe the firm’s “comfortable debt levels with limited capex plans provide room to explore additional growth opportunities and drive efficiency at the newer hospitals”. The analysts expect revenue from international tourists to increase, as it has hospitals across major cities in India. Revenue from international patients has already jumped to 1.5X of pre-covid levels, added the analysts.  

    Analysts Bafna and John like the company’s strategy to strengthen its foothold in the oncology hospital space by focusing on acquiring standalone hospitals from tier-2 cities, where the cost of acquisition will be cheaper. HealthCare Global expects its newly acquired hospitals to be operational in 18-24 months, they added. The analysts expect the company’s net profit to grow at a CAGR of 29.2% over FY22-24.

    1. Home First Finance Company India: Motilal Oswal initiates coverage on this housing finance company with a ‘Buy’ rating and a target price of Rs 1,020. This indicates an upside of 16.6%. The stock is currently trading in the PE Buy Zone.

    Analysts Abhijit Tibrewal and Nitin Agarwal expect the company’s assets under management (AUM) to grow on the back of its rising disbursements, co-lending partnerships and diverse marketing channel. The analysts added, “Home First’s first mover advantage in technology along with its strategic digital partnerships has resulted in robust underwriting, quicker turnaround and superior asset quality”.

    The analysts believe the company is well placed to mitigate a potential margin compression given its cost efficiencies. They also anticipate the asset quality to remain stable and healthy as its net non-performing assets stood at 1.8% in FY22. Analysts Tibrewal and Agarwal expect Home First Finance’s AUM and net profit to grow at a CAGR of 29% and 24%, respectively, over FY22-25.

    1. Narayana Hrudayalaya: Prabhudas Lilladher maintains a ‘Buy’ rating on this healthcare facilities company with a target price of Rs 810, indicating an upside of 14.8%. The stock is currently trading in the PE Buy Zone.

    Narayana Hrudayalaya inked an agreement with Shiva and Shiva Orthopaedic Hospital to acquire its orthopedic and trauma hospital (Sparsh unit) in Bengaluru on a slump sale basis for Rs 280 crore. Param Desai and Sanketa Kohale said, “Though the acquisition looks expensive, it will offer the entire spectrum of services in Health City.” They further added, “Sparsh unit possesses 100 operational beds since a decade, which has generated Rs 49 crore and Rs 18 crore revenues in FY22 and FY23 (4 months) along with healthy profitability.” 

    The analysts believe that the company’s aggressive capex plans, which include a new Cayman unit, inorganic opportunities and greenfield/ brownfield expansion in India over the next three years will enhance growth visibility beyond FY24. Overall Desai and Kohale expect an EBITDA CAGR of 22% over FY22-24.

    1. Balkrishna Industries: Hem Securities initiates a ‘Buy’ call on this tyre manufacturer with a target price of Rs 2,293. This indicates an upside of 12.7%. The stock is currently trading in the PE Buy Zone.

    The analysts note, “We believe Balkrishna Industries will continue to perform well over the next few quarters due to a robust demand environment.” They also believe that the company's export oriented business model, labor cost benefits and aggressive marketing may help them in outperforming its peers.

    “With the help of capex, they are also increasing their capacity which will help them in gaining market share,” the analysts added. The tyre manufacturer is targeting doubling global market share to 10% vs. 5.5-6% currently, and its aggressive marketing and promotional activities are improving brand visibility. 

    1. IIFL Wealth Management: BOB Capital Market maintains a ‘Buy’ call on this financial services company with a target price of Rs 2,277, indicating an upside of 31.8%. The stock is currently trading in the PE Buy Zone. 

    Mohit Mangal writes, “IIFL Wealth has successfully scaled its annual recurring revenue (ARR) business over the last three years and aims to have 80-85% of its topline from recurring streams,” and he believes this strategy will ensure a favourable asset mix of both debt and equity, and garner traction in the alternative investment space. 

    This financial services company plans to target Rs 5-25 crore clients due to low competition levels and robust growth in clientele. Mangal remains positive on the stock and concludes, “The company has maintained a niche position in the under-penetrated wealth management business, enjoys a track record of innovative wealth products and has a strong team leader-driven model that boasts of low attrition at both the client and team level.”

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    6
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    09 Sep 2022
    Adani's wealth grows as others shrink; Indian companies plan 'once in history' capex spending

    Adani's wealth grows as others shrink; Indian companies plan 'once in history' capex spending

    It's difficult for Indian parents to point to Gautam Adani while telling their kids, "Don't you want to become like him?" Adani is after all, a college dropout. He was probably the kid adults called "a bad influence". 

    Now, to the frustration of Indian parents everywhere, Adani has become even richer, with Bloomberg placing him as the third wealthiest man in the world in 2022. 

    In this week's Analyticks:

    • It's raining gold: Adani's wealth rose even as many billionaires became poorer
    • Capex spending is on fire for Indian businesses: Companies are scaling up investment to meet domestic demand

    In 2020, Gautam Adani was far from wearing the "richest three" crown. He had just $10 billion in net worth and was behind Mukesh Ambani in the billionaire race. 

    Come 2022, and how fortunes have changed. Adani has seen a jump in his net worth that beats any fairytale - it has multiplied 14X between Jan 2020 and now. He is now worth $143 billion, making him the third richest behind just Elon Musk and Jeff Bezos. Ambani is behind him, ranked tenth. 

    Much of this wealth has been driven by the rise of Adani stocks, which are at eye-watering, triple digit PE valuations. Adani Green Energy trades at 764 PE, while Adani Transmission trades at 458 PE.

    Compare this to Reliance Industries, which trades at 26.3 PE. Despite the octopus nature of Bezos' Amazon's business, it trades at 116 PE, while Musk's Tesla trades at 99.1. 

    The rapid rise in Adani stocks over the last two years explains Gautam Adani's jump in the wealthiest list, even as other fortunes crumbled as markets turned volatile.  Musk and Bezos, for example, saw their net worth decline as the value of Amazon and Tesla stocks fell in the year to date. Adani is also well ahead of other Indian billionaires.

    The Adani group currently has a combined market cap of over $250 billion (approximately Rs 20 lakh crore). However, the challenge is that these businesses are "deeply over-leveraged" and loaded with low cash flow and high debt, as a recent CreditSights report put it, which means that Adani's net worth “is paper wealth, and tied to the valuations of his holdings in the Adani Group’s stocks". There's also the concern of the group's non-transparent shareholding, with anonymized shareholders like the APMS Investment Fund holding large stakes in Adani companies.

    Rising debt in Adani companies is in contrast to Reliance's efforts to sharply cut debt levels. The crown is shiny for Adani, but high levels of debt are a shaky foundation to build a business, or net worth on.  


    Capex forecasts show aggressive spending plans in FY23

    The outlook for India is brighter than the global economy, and that is showing up in the aggressive spending plans among Indian businesses. International as well as domestic analysts are bullish on spending, thanks to the healthy balance sheets of the Indian private sector, and rising domestic demand. Government policies have also been increasingly supportive of Indian industry, which is giving businesses confidence that the large investments they make will pay off. 

    As a result, the planned capex for the year across major industries is soaring. This screener (subscriber) looks at the estimated annual capex spending for India's top businesses in FY23. Industries such as refineries, oil production, electric utilities and telecom are all seeing big spending estimates. 

    This spending is partly driven by where India is on the development curve. As India's GDP ramps up, companies are building the "once in a country's history" essential infrastructure, that is needed to take the economy to the next level. This is like the infrastructure spending European and US economies saw in the 1950s and 1960s, and China saw in the 1970s as their GDP jumped. Large capex spends are being earmarked in critical sectors like metals, electric utilities, telecom and cement to meet the rising demands of Indian consumers.

    For example, cement companies like Ultratech Cement and Grasim Industries have planned annual capex in the range of Rs. 50,000 crore. Sectors like auto are also seeing big outlays from companies like Tata Motors, as businesses focus on new models and the EV transition. 

    Companies are also moving up the value chain as their prospects improve. Rising global market share for India's chemical and fertilizer companies are pushing them towards higher-margin specialty compounds, and they are investing to build capacity here. The major companies in real estate and retail such as Avenue Supermarts, Prestige Estates, and Phoenix Mills, have also earmarked annual capex in the range of Rs. 20,000 crore. 

    The full screener on planned capex spends is here.

    3
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    09 Sep 2022
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. Ashok Leyland: This truck manufacturer’s stock touched its all-time high of Rs 169.4 on Tuesday and rose by 11.8% over the past month till Thursday. The surge in stock price comes on the back of a robust business outlook and a major deal win. This month, the company bagged orders worth $75 million to supply 1,400 buses in the UAE. This is the largest order for buses it has received in the UAE to date.

    The company’s total wholesales for the month of August rose by 51% YoY, mainly driven by the surge in demand for trucks and buses. The management says the company’s diverse product portfolio mix and robust distribution network led to an increase in sales and market share. The firm’s domestic market share in trucks improved by 490 bps YoY to 31.1% in Q1. This healthy performance helped the stock make it to this screener which lists companies that outperformed their industry in the past 90 days.

    The management expects the demand environment to improve due to increasing construction, infrastructure and mining activities. It also expects the re-opening of schools, colleges and offices to improve demand for buses. The light commercial vehicle segment’s sales volume will continue to grow on rising demand from the e-commerce and agriculture sectors. The street largely holds a bullish outlook for the stock, with a consensus recommendation of ‘Strong Buy’. According to KRChoksey, the company’s pipeline of new product launches will help increase its market share. The management anticipates better profitability in the coming quarters on softening commodity prices and a robust demand environment.

    1. Federal Bank:This bank's stock rose 9% in trade on Monday on speculative reports of the bank merging with another private bank. However, the bank denied the news and called it speculative. The stock tanked 8% after the bank issued this clarification. However, this did not affect the stock’s overall performance as it shows up in a screener where it is outperforming its industry by 14.2% in the past 90 days. It also shows up on the screener identifying stocks where FIIs increased their holding.

    In a recent interview, the bank’s CEO Shyam Srinivasan said that rupee depreciation has helped improve the bank’s NRI (non-resident Indians) funds account. 21% of India’s remittances are now coming in through the bank. He also adds that earlier these funds were just lying with the bank, but now, the activity in these accounts has improved with investments into properties and other finances. He expects remittances to improve in the upcoming quarter. 

    Recently brokerage Nirmal Bang gave a ‘Buy’ rating for this stock as its retail loan AUM (assets under management) improve to 55% in Q1FY23. It also expects asset quality to improve. What impressed the brokerage was the corrective measures taken by the bank to disburse small ticket-sized corporate loans to counter risk. The bank also reported an improved net interest margin to 3.2% in Q1FY23. However, the brokerage believes that the bank should have a higher contingency buffer.Trendlyne’s consensus recommendation saw 21 brokerages recommending a ‘Buy’ on the stock in September.

    1. Brigade Enterprises: This realty stock hit its all-time high of Rs 575.4 on Wednesday and has been on an upswing since announcing its Q1FY23 results on August 2. The company’s net profit rose over 4X YoY to Rs 87.7 crore beating Trendlyne’s Forecaster estimates by 161%. Its sales bookings in the residential segment jumped 70% YoY in the same period. The realty firm benefitted from the resurgence in demand for housing, office spaces, and travel as it is present in the residential, commercial, retail, and hospitality segments.

    The management expects a favourable demand environment to continue over the coming quarters, and to meet this demand it has added projects worth Rs 500 crore in H2CY22. It plans to add more projects in the remainder of FY23. The company has been funding these projects from the proceeds from its qualified institutional placement (QIP), through which it raised approx Rs 500 crore. This has helped it maintain strong cash flows and a healthy balance sheet. It shows up on this screener which lists companies whose cash flows from operations have been consistently improving over the past two years.

    Going forward, the management anticipates leasing out 1.7 million square feet of vacant space by the end of FY23. It expects the growth in rental income to be driven by a rise in demand for office space and retail space. The recovery in rental income will help reduce the risk associated with the residential segment, it added. In the coming years, the company plans to focus on increasing its presence in newer markets, specifically in the residential and commercial segments.

    1. Angel One:The stock of this broking company jumped nearly 14% after it released its business update for August 2022. The company also outperformed the Nifty 500 index by roughly 15 percentage points in the past week.Angel One acquired 4.5 lakh new clients in the month gone by, up by over 28% on a MoM basis. This is especially noteworthy as the company’s client acquisition run rate had fallen to 3.4 lakh clients in June and July after peaking in May.

    The average daily  orders rose to over 36 lakh after continuously falling between February and July owing to tepid market activity and bearish sentiment. The Indian markets came alive in August backed by renewed investment fervor especially among foreign institutional investors. The FIIs pumped in roughly Rs 54,000 crore in the Indian equity markets in August, highest since December 2020. Higher market activity also caused Angel One’s average daily turnover to rise over 20% MoM across its product segments. However, the company ended up losing market share in the derivatives segment while it gained over 3% share in the commodities segment. Angel One now holds over 50% market share in the upcoming commodities segment. 

    The company now has a client base of over 11 crore and its management is confident that strong client acquisition growth will continue, backed by higher participation of millennials in the markets. Prabhakar Tiwari, Chief Growth Officer, Angel One believes that the total number of demat accounts in the country will cross the 20 crore mark over the next three to four years, doubling from current levels. The company is also in the process of deploying its ‘Super App’ to deliver a personalised investment experience. Angel One beat consensus estimates of analysts in Q1FY23 and is all set to clock over 20% topline growth in FY23.

    1. One97 Communications (Paytm): This internet company re-appointed Vijay Shekhar Sharma as its MD & CEO in the last week of August. According to reports, it looks like the CEO is on borrowed time to convert its books to black, given the stock lost 60% of its value since its IPO in November 2021 and investors were not happy.

    However, recently Paytm has been in the news for entirely different reasons. The stock fell 2.5% on September 3 after the ED raided the premises of Paytm along with Razorpay and Cashfree, on suspicion of a loan racket run around by Chinese nationals. According to reports, ED seized some Rs 17 crore worth of funds in the form of merchant IDs and bank accounts. Although the company gave an official clarification saying that none of the funds frozen by ED belongs to Paytm or its group companies, the investors are yet to gain their trust back in the stock. 

    On September 6, the company published its monthly operational update. Given that the Reserve Bank of India (RBI) has banned Paytm from onboarding new customers, its monthly transacting users (MTU) are still up in August. However, this is just an 11.3% increase since the ban. The number of loans disbursed increased 246% YoY while gross merchandise value is up 72%. The management says that it is seeing a lot of upsell opportunities in this business. Paytm will have to focus on getting the maximum out of its existing users, given that it will take at least 3-5 months for the RBI to take a call on the imposed ban.

    Trendlyne's analysts identify stocks that are seeing interesting price movement, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener Forecaster Annual Capex (Capital …
    08 Sep 2022

    Forecaster Annual Capex (Capital Expenditure) for Companies: One Year Forward

    Estimated capital expenditure for companies one year forward. Only non-zero values are shown.
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    07 Sep 2022
    Chart of the Week: India has a young working population. But it may not fully benefit from it

    Chart of the Week: India has a young working population. But it may not fully benefit from it

    By Abdullah Shah

    The Reserve Bank of India (RBI) projects India’s GDP to grow by 7.2% in FY23, which places the country among the fastest growing economies in the world. One of the reasons for the rapid growth is that India entered a demographic dividend starting 2018. 

    A demographic dividend occurs when a country’s working population is larger than its dependent population. When people have fewer dependents (children and elderly parents), they tend to take more risks, travel for work, and also take up high-productivity jobs. This drives higher GDP growth. 

    The ratio of India’s working population to total population is currently higher than countries like China, Japan and Brazil. The population of these countries have already started to decline, while India’s working population will increase till 2045. It will also exceed China’s population by 2030. 

    While having a large labour force is an opportunity for countries, translating it into high growth is not straightforward. India has not made significant headway in skilling and educating its workforce. And almost 83% of the workforce is employed in the unorganised sector. 

    Employability of India’s workforce was 47.4% in 2019. It fell to 46.2% in 2022 due to the lockdown restrictions during the COVID-19 pandemic owing to online classes, as well as long school and college closures. 

    As India shifts from an agricultural nation to a manufacturing/services economy and an exporting powerhouse, policy-makers will have to focus on increasing employability, and bringing more people into the organized sector. It also needs to increase labour participation for women. India currently ranks 178 out of 187 countries in female workforce participation according to the World Bank and its female labour participation rate is 19%, among the lowest in the world.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    06 Sep 2022
    Five analyst stock picks this week

    Five analyst stock picks this week

    By Suhas Reddy
    1. Aptus Value Housing Finance India: LKP Securities maintains its ‘Buy’ rating on this housing finance company with a target price of Rs 526, indicating an upside of 46.7%. Analyst Ajit Kumar Kabi believes the company is well-placed to capitalise on improving business conditions, given its robust cash positions and underwriting practices. The analyst further adds that the company’s return on assets (RoA) has been best-in-class among its peers on a high net interest margin (NIM) and with controlled operating expenses. He expects an NIM of 10.5% and a RoA of 7% in FY23.

    Kabi says, “The company has a robust tech-driven customer acquisition platform and follows a stringent credit underwriting process”. He believes this has enabled the company to keep its net non-performing assets (NNPAs) below 1% for several years. Also, its collection efficacy surpassed the pre-covid level and stood at 101.2% in June. Kabi expects the company’s net profit to grow at a CAGR of 40.7% over FY22-24.

    1. Nippon Life India Asset Management: Axis Securities maintains its ‘Buy’ rating on this asset management company with a target price of Rs 360, indicating an upside of 20.9%. Analysts Sumit Rathi and Dnyanada Vaidya believe the firm’s growth trajectory is intact given rising inflows from tier 2 & 3 cities, and its strong distribution network. Its extensive distribution network enables it to penetrate the underpenetrated Indian market, the analysts added. The analysts also expect Nippon Life to expand its presence and scale up its offshore business via international tie-ups and partnerships.

    Rathi and Vaidya notes, “Nippon Life has adopted a differentiation and low-cost approach and is focused on scaling up its Alternative Investment Fund (AIF)/ Portfolio Management Services (PMS) businesses''. They believe this strategy along with its strength in the retail segment resulted in the company amassing the largest investor base in the industry with 1.7 crore investor folios. The analysts expect the company’s net profit to grow at a CAGR of 9.9% over FY22-24.

    1. Jubilant Foodworks: Ashika Research maintains its ‘Buy’ rating on Jubilant Foodworks with a target price of Rs 710, indicating an upside of 17.4%. The brokerage expects the company’s revenue growth to accelerate as it believes customers are shifting to organised quick service restaurants (QSR) from unorganised ones. It believes the company will maintain its dominant position in the Indian QSR space as it is expanding its store network aggressively and diversifying its cuisine portfolio. The firm is also focusing on scaling up its international operations, it added.

    The brokerage is bullish for the company as it won exclusive franchise rights to operate the Popeye’s brand restaurants in India, Bangladesh, Nepal and Bhutan. It believes the strategy to diversify its cuisine portfolio will also aid in market share expansion. The brokerage house said, “strong cost control and management commentary on aggressive store additions and thrust on digital & tech initiatives provide a strong growth outlook”. The broker expects the company’s profit to grow at a CAGR of 30.4% over FY22-24.

    1. Hindustan Aeronautics (HAL): ICICI Securities maintains a ‘Buy’ call on this aircraft manufacturer and increases the target price to Rs 2,665. This indicates an upside of 12.1%. Abhijit Mitra, Mohit Lohia, and Pritish Urumkar point out that the order lineup for HAL over the next three years is worth Rs 1.5 lakh crore, which includes manufacturing orders worth Rs 45,000 crore. The company’s management is confident of maintaining 24-25% EBITDA margins and set its internal target of Rs 2,500 crore in export revenues by FY25. 

    The analysts note, “The biggest certainty to our valuation is the order book, which is expected to cross Rs 1 lakh crore by FY22-23.” The defence company’s current order book stands at Rs 85,000 crore which includes a fresh order of Rs 6,000 crore in Q1FY23. They further add, “There are hardly any defence primes in the world which manufacture combat aircraft and have an equivalent book-to-bill ratio.”

    1. Grasim Industries: Motilal Oswal maintains a ‘Buy’ call on this cement producer with a target price of Rs 1,880, indicating an upside of 10.1%. “Garsim’s FY22 Annual Report highlights integration across the value-chain and diversification into new businesses,” say analysts Sanjeev Kumar Singh and Mudit Agarwal. 

    The company’s standalone revenue increased 68% YoY to Rs 20,900 crore, EBITDA increased 105% YoY to Rs 3,200 crore and EBITDA margin increased by 2.8 basis points YoY to 15.4%. According to the analysts, “The improvement in performance was led by higher sales volume and better realisation, which was partly offset by a rise in raw material and input cost in H2FY22 amid a volatile external environment.”

    Singh and Agarwal are positive on the cement manufacturer on the back of the company expanding capacity to cater to the growing demand across businesses and its foray into high growth businesses such as paints and B2B e-commerce.

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    03 Sep 2022
    Reliance Jio v/s Bharti Airtel: Who will win the 5G war?

    Reliance Jio v/s Bharti Airtel: Who will win the 5G war?

    By Deeksha Janiani

    India registered strong double-digit GDP growth in the first quarter of FY23. But the 13.5% growth rate is lower than RBI's estimate of 16.2%. India faces multiple speedbumps - rising interest rates, uneven monsoons - but is better placed than developed countries that are struggling with high inflation, and China with its self-goals of city-wide Covid lockdowns.

    A rebound in the services sector has helped deliver India's Q1 growth. Within services, a Big Two rivalry in a key industry - telecom - is driving a big cycle of spending.

    In this week’s Analyticks:

    • Reliance Jio v/s Bharti Airtel: Who will win the 5G war?
    • Screener: Companies outperforming their industry in returns on capital, and growth

    Let’s get into it.


    Will Reliance Jio's 5G launch help it gain over Bharti Airtel?

    For businesses, the rise of a new technology is a fresh chance to win market share. And it looks like Reliance Jio is counting on its 5G rollout to build a massive lead over its competitors. Reliance Chairman Mukesh Ambani announced a special Diwali present for Indians in the 45thannual general meeting of Reliance Industries. If you are a Reliance Jio user living in any of the four metros or major cities like Bangalore, Ahmedabad and Pune, you will be able to  access 5G technology by this Diwali.

    5G opens the door to much faster data. While 4G gives us a download speed of upto 150 mbps, 5G offers speeds of upto 10 gbps, nearly 67 times higher. The upload speed is also 20 times higher than that of 4G. People living in smaller cities and towns are expected to get Jio 5G by December 2023. 

    This ambitious plan comes at a hefty price tag for Reliance. 

    The company will incur a capital expenditure of Rs 2 lakh crore via its telecom arm Reliance Jio Infocomm, to roll out 5G services. The planned capex spend includes Rs 88,078 crore spent on the 5G spectrum auction held recently. The remaining amount is earmarked for setting up 5G network infrastructure. 

    Notably, the spectrum cost is evenly spread out over a period of 20 years. So including two spectrum installments, Reliance Jio is set to spend over Rs 1.25 lakh crore on the rollout of 5G services in the next 18 months. This is 20% more than the last three years of combined capex for Jio.

    Meanwhile, Bharti Airtel is also focusing on its 5G rollout plans. The telecom major plans to cover the entire country with its 5G services by the end of March 2024, at half the cost Reliance is spending.

    According to its recent earnings call, Bharti will incur a capex for the next three years similar to what it spent between FY20 and FY22 - which is around Rs 75,000 crore. The majority of the capex will be spent in the next 18 months itself. 

    Now, the key question is: which of these telecom majors will emerge as the more successful 5G service provider?

    Throwing money at the problem, and winning: Reliance Jio’s lightning fast growth in the last five years

    Thanks to its parent company’s deep pockets, Reliance Jio witnessed massive network expansion as well as revenue growth (which jumped 4X) in just five years. This growth was fueled by the doubling of its total subscriber base, which crossed the 40 crore mark in FY21. In fact, Jio surpassed Airtel on this metric by FY20, within three years of its 4G launch. 

    However, this blockbuster growth came at a high capex cost for Reliance Jio. The subsidiary saw negative free cash flows of over Rs 1.10 lakh crore between FY18 and FY20, backed by higher investments. It finally generated positive free cash flows in FY21, only to see them fall materially in FY22.

    Now Jio is embarking on another capex cycle, which may once again strain its free cash flows. 

    At the consolidated level, Reliance Industries generated operating cash flows of around Rs 1.10 lakh crore in FY22. This should give some comfort to investors for planned 5G investments if we assume a similar level for FY23.

    However, there are also other competing investments. The company announced fresh investments of Rs 75,000 crore in the oils to chemical business. There are more long-term commitments on the new energy side which are over Rs 6.5 lakh crore. So there is a good chance that the company may see negative free cash flows for FY23 and look for external sources of funding. 

    Reliance Jio is going for a costlier 5G approach. But is the price tag worth it?

    Bharti Airtel and Reliance Jio have chosen two different approaches to deploy 5G technology. Airtel is going for the cheaper, and globally accepted non-stand-alone approach while Jio is opting for the stand-alone approach.

    In Airtel's non-stand-alone (NSA) approach, a telecom operator delivers the 5G radio signal over existing 4G network infrastructure.  A standalone (SA) 5G network on the other hand, runs on an entirely new network infrastructure (say new radio towers) which requires higher capital investments. 

    Jio will develop this new infrastructure in-house and leverage its partnership with Qualcomm. The advantage of going for the SA structure is that it offers ultra-low latency which basically means minimal time lag in data transfer. This makes it suitable for applications in remote surgeries, gaming and robotics. 

    However, the challenge here is that the ecosystem for this structure is not yet developed. Very few mobile phones can actually support a 5G SA structure. 

    To enable the new structure, Jio acquired the highly expensive 700 MHz frequency waves along with the 3.3 GHz waves in the recent spectrum auction. This may not give Jio much of an advantage. According to Nokia, the 700 MHz band does offer better area coverage but the speed is only a little bit better than 4G. The same sentiments were echoed by Gopal Vittal in the recent earnings call. 

    The difference in these approaches explains why Airtel will roll-out 5G services at half the capex cost of Reliance Jio. Airtel can always opt for the advanced SA structure later on once the ecosystem is well established and there is evidence of higher revenue per user (ARPU).

    Currently, none of the global telecom operators are making any incremental ARPU on the service, and it does make sense to wait and watch before going all out for an expensive architecture. 

    We won't know right away which strategy will pay off. Will Jio grab a higher share in the subscriber base and better ARPU with 5G, or will Airtel, the more 'sensible' player, win out? Analysts, meanwhile, anticipate a higher jump in Bharti Airtel’s net profits in next two years.


    Screener: Sector outperformers in capital returns and revenue growth

    This screener reflects stocks which outperformed the industry on annual return on capital employed (ROCE), return on equity (ROE), annual net profit growth and revenue growth. 

    It is dominated by stocks from the pharmaceutical industry and also includes stocks from auto parts and equipments and footwear. Major stocks featured in this screener are Divi’s Laboratories, Tube Investments, Ajanta Pharma and Metro Brands.

    Divi’s Laboratories outperformed the pharmaceutical industry annual ROCE by 9.4 percentage points as well as surpassed the annual revenue YoY growth of the industry by 18.5 percentage points. Growth in the custom synthesis segment and efforts towards backward integration and debottlenecking aided this outperformance. 

    Tube Investments outperformed the auto parts industry in annual ROCE by nearly 10 percentage points and in annual revenue growth by over 80 percentage points. Its revenue growth was primarily driven by its engineering business which did well owing to market share gains and doubling of exports.

    Metro Brands outperformed the footwear industry in annual revenue growth by 18.1 percentage points. This is helped by the growth in sales volumes due to reopening of offices , festive and the wedding season. Its annual PE TTM is also lower than the industry average. This has helped the stock to outperform the industry returns by 18 percentage points. 

    You can find some popular screeners here.

    1
    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    02 Sep 2022
    Five Interesting Stocks Today

    Five Interesting Stocks Today

    1. Inox Leisure: This leading multiplex operator laid out its expansion plans in its annual report released on August 30.  However, this failed to move the needle materially in the market and the stock only gained 2% in the subsequent two trading sessions. Inox Leisure seeks to open around 60 additional screens in the remaining part of FY23, after having launched 44 screens in Q1FY23. This is 35% more than its initial target for the year. Additionally, Inox aims to open around 834 screens after FY23 which would take its total screen count to over 1,500 in the longer term. This is likely to further strengthen the market position of the soon-to-be merged entity of PVR INOX.

    However, the market is skeptical about the sustenance of high footfalls in cinemas, in the age of streaming. Although Inox Leisure’s footfalls comfortably crossed the pre-Covid levels in Q1FY23, the response to recent Bollywood releases has been rather lukewarm. Big-ticket films like Laal Singh Chaddha and Raksha Bandhanfailed to appeal to the masses. With the advent of OTT platforms, only superior content like that of RRR, KGF 2 and Bhool Bhulaiyaa 2 are driving the audience back to the cinemas. With the target audience having access to multiple digital modes of entertainment including Instagram, and YouTube, theaters are having to compete hard for customer attention and wallet share, as noted by Inox in its latest annual report. This is a major risk factor for multiplex chains mulling future expansions.

    Another factor going against Inox is therecent complaint of a non-profit organization namely CUTS to Competition Commission of India against its proposed merger with PVR. Now, Inox is caught up in its own drama -  all eyes are on the upcoming releases of Brahmastra, Vikram Vedha as well as the response of CCI to this complaint.

    1. Spicejet: This airline company’s stock price fell over 3% on Thursday post its Q4FY22 and Q1FY23 results announcement. The company had cited a ransomware cyber attack on its IT systems as the reason for the delay in announcing results. In Q1FY23, the airline’s losses widened to Rs 789 crore compared to a loss of Rs 729 crore in the same period the previous year. This is despite its revenue jumping over 2X YoY in Q1FY23 on a low base, due to the pandemic Q1 last year.

    Record high fuel prices and the depreciating Indian rupee impacted the bottom line. The company’s losses widened YoY in Q4FY22 as well, leading to a cash crunch at the airline. As a result, Spicejet delayed salaries for the second month in a row, according to reports. The company also announced the resignation of its Chief Financial Officer Sanjeev Taneja with effect from Wednesday.

    The disappointing results come after Spicejet’s Chairman Ajay Singh said that the airline is looking to raise around Rs 2,000 crore. In reaction, its share price rose over 3% on August 23. In the past month, the stock price has risen over 20% and mutual funds also increased their shareholding in this company. Despite the widening losses, the management remains optimistic on the back of a fresh capital inflow of Rs 2,000 crore. It also said that Spicejet had the highest domestic passenger load factor (86.4%) in the industry in Q1FY23. To conserve costs,  the company plans to induct more fuel-efficient Boeing 737-8 MAX aircraft amid elevated fuel prices.

    1. ABB India: This heavy electrical equipment stock has been rising for the past five sessions. It rose 2% on Tuesday and touched an all-time high of Rs 3,273.2. This comes after the company announced the launch of its ‘Smart Power Portfolio’ in its Bangalore plant. With the new system in place, ABB India will focus on providing better automation services, especially to its manufacturing clients. This stock is in demand as it also shows up on the screener of stocks overbought on MFI (money flow index) and RSI (relative strength index).

    After market hours on Tuesday, the company announced itsdivestment in Turbocharging Industries and Services India for a consideration of Rs 355 crore. It was earlier valued at Rs 310 crore, according to reports. The stock rose 4% in trade on Thursday after this and touched a new 52-week high of Rs 3,429.3.

    Although the company reported a rise of 99.6% YoY innet profit, brokerages do not seem particularly enthused with the Q2CY22 results. According to Trendlyne’s consensus recommendation, 14 recommend a buy while 8 recommend a ‘Hold’ and one recommends ‘Sell’ on the stock in August. This is due to the short-term nature of the orders received by the company.

    HDFC Securities maintains a ‘Sell’ on the stock as it wants to assess the growth of the company despite the surge in short-term orders, profit and revenue to make sure that further upcycle of the stock is not hindered. Prabhudas Lilladher and Geojit BNP Paribas remain cautious and maintain ‘Accumulate’ on the stock as they see long-term growth with an increase in capex, price hikes, increase in clients and improving exports.

    Interestingly, ABB India’s Managing Director Sanjeev Sharma on Tuesdaysaid that the company is not seeing any slowdown in orders and is focused on building upon opportunities arising from the domestic demand.

    1. Biocon:This biotechnology company is making news in the stock market - but for all the wrong reasons. On August 25, the Central Bureau of Investigation (CBI) filed a charge sheet against five officials of Biocon's arm Biocon Biologics in an alleged bribery case, according to reports. The stock traded flat immediately after this news; however, it was one of the top loser stocks on Thursday, falling more than 2.5% in trade.

    Biocon touched a 52-week low of Rs 297.5 on Thursday after an inspection report was given by the US FDA. According to the company’sfiling, the US FDA issued Form 483 (a form issued by the regulator when it observes a violation of the Food Drug and Cosmetics Act) with 11 observations for two sites in Bangalore and six observations for the Malaysia site. According to the filing, the company needs to work on improving its microbial control at the plant sites, enhance quality oversight and work on revamping software that supports risk identification and assessment.

    With all this going on, the stock appears on thescreener where two brokers downgraded their target price for the stock while one downgraded its rating in the past month. However, the consensus recommendation for the stock by 14 analysts is ‘Buy’, according to the Forecaster consensus recommendation. Four analysts maintain ‘Hold’ and four maintain a ‘Sell’ on the stock.

    1. Mazagon Dock Shipbuilders: This shipping company outperformed the Nifty 500 by 27.4% over the past week till Thursday. The surge in the stock comes on a robust business outlook as the Ministry of Defence approved a positive indigenisation list on Monday, according to reports. The list follows two previous lists approved in December 2021 and March 2022. This list contains 780 items which will be indigenised and procured domestically over a period of time. The management believes it is well placed to benefit from the push for indigenisation as it is the only manufacturer of destroyers and submarines in India. So far, it has been successful in indigenising its ships as the percentage of locally produced components in the ships it builds has steadily increased to 75% from 42% in the 1990s, according to ICICI Securities.

    The company’s strongQ1FY23 results have also aided positive price movement. Its net profit jumped 2.2X YoY to Rs 224.8 crore and revenue rose 83.7% YoY. Since releasing its Q1 results on August 10, the stock has risen by 42%. Due to this surge in share price the company made it to a screener that lists stocks which are overbought in the Money Flow Index.

    For the remainder of FY23, the company has an order book of Rs 43,343 crore and expects the order inflow to increase over the coming years. In the long term, the management has two major projects involving the construction of submarines and new generation destroyers, with a combined value of Rs 93,000 crore. The management has guided revenue growth of 15-20% going ahead in FY23.

    Trendlyne's analysts identify stocks that are seeing interesting price movement, analyst calls, or new developments. These are not buy recommendations.

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline created a screener Data screener
    01 Sep 2022

    Data screener

    Copy LinkShare onShare on Share on Share on
     
    logo
    The Baseline
    30 Aug 2022
    Which Analysts Got it Right? Tracking Five Buy Calls Made in March 2022

    Which Analysts Got it Right? Tracking Five Buy Calls Made in March 2022

    This week we take a look at how accurate analysts have been in predicting a stock’s share price growth. We look at analyst buy calls from March 2022 to see if the stocks they chose beat their target prices in the months that followed.   

    1. TVS Motors: This two-wheeler manufacturer was trading at Rs 625.7 on March 31, 2022 and has risen by 57.5% since. It is currently trading at Rs 985.6. 

    In March, multiple analysts and brokerages were bullish on the company. Brokerages like Prabhudas Lilladher, IDBI Capital, Geojit, Chola Wealth, and Axis Direct gave a ‘Buy’ rating to the motor company in March with target prices ranging from Rs 669 to Rs 751, with an average broker upside of 8.3%. 

    In the months that followed, TVS outperformed all these targets. Analysts were positive on the company on the back of new product launches, aggressive plans in the eclectic vehicles segment, and the domestic market recovery post-Covid-19 lockdown. 

    1. Eicher Motors: This truck and two-wheeler manufacturer’s stock was trading at Rs 2,457.1 on March 31 2022. Since then it has risen by 36.7% to Rs 3,358.7. 

    The average target price in March for Eicher was Rs 2,852.9 and the average broker target upside was 8.8%. Brokerages like Prabhudas Lilladher, Motilal Oswal, and Geojit BNP Paribas had a ‘Buy’ rating on Eicher as of March 2022. Their target prices ranged from Rs 2,569 and Rs 3250. Since then, the stock has exceeded these target prices and easily beat the average broker upside of 8.8%.

    The analysts were positive on the company’s prospects given the new launches, geographic expansion, ramp-up of exports, and easing of supply chain issues.

    1. Bajaj Auto: This two-wheeler stock was trading at Rs 3,653 in March 2022, and since then it has increased by 11.8% to Rs 4,084.8. Quite a few brokerages were optimistic about this auto manufacturer’s prospects in March. The average target price was Rs 4,072.6 and the average broker target upside on the stock was 7.9%.   

    In March, brokerages like Geojit BNP Paribas, Axis Direct, Prabhudas Lilladher, Sharekhan, HDFC Securities, and LKP Securities had a ‘Buy’ call on the company. Among these calls, the stock met the target price of Geojit BNP Paribas and Prabhudas Lilladher, whose targets were Rs 4,040 and Rs 3,911, respectively. The company has also beat March’s average broker target upside of 7.9%.

    Analysts were bullish on the auto stock on the back of growth in demand in the three-wheeler segment, new product launches, increase in production capacity, and rising exports. They expected the company to increase its market share both domestically and internationally.

    1. Reliance Industries:This conglomerate’s stock was trading at Rs 2,634.7 on March 31, 2022, and since then it has risen by just 0.1% to Rs 2,637.9. Many brokerages had a positive outlook on the company’s prospects in March this year. The average target price from analysts in March was Rs 2,833.8 and the average broker upside on the stock was 2.6%.

      Brokerages like Prabhudas Lilladher, ICICI Securities, Motilal Oswal, and Geojit BNP Paribas gave a ‘Buy’ rating to the refinery company despite its high valuation, and target prices ranged from Rs 2,758 to Rs 3,045. Reliance did temporarily beat the average broker upside of 2.6%, when it touched Rs 2,819.8 in April 2022. However the price has fallen since then. 

    Analysts were bullish on this stock given its robust cashflows and balance sheet enabling it to make strategic investments across business sectors. They also expected Reliance Jio’s average revenue per user to increase and the company’s retail business to expand leading to higher revenue.

    1. Sun Pharmaceuticals: This pharmaceutical company’s share price on March 31, 2022 was Rs 914.8.  The average target price was Rs 993.7 indicating an upside of 9.7%.

    Sun Pharma is currently trading at Rs 893.1, down 2.4% since March 2021. However, it met various targets from analysts as it hit its five years high of Rs 967.1 on April 29, 2022.

    Brokerages like Edelweiss, Geojit, and ICICI Direct had a ‘Buy’ call on the pharma company with target prices of Rs 940, Rs 948, and Rs 965. The stock met these targets along with a target from Motilal Oswal of Rs 960, after which the brokerage set a new target price of Rs 970. Targets from brokerages like HDFC Securities, Prabhudas Lilladher, and BOB Capital Markets which are above Rs 970 are yet to be reached. 

    The analysts were positive on the stock because of its diversification in the United States and Canada market into specialty products like Ilumya, Levulan, BromSite, Cequa, Xelpros, etc.

    You can track analyst calls with this screener. To see calls in previous months and quarters, use the Screener Rewind feature on this screener. 

    Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

    2
    Copy LinkShare onShare on Share on Share on
     
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd